
Retractable Technologies RVP
$ 0.69
0.36%
Quarterly report 2025-Q3
added 11-14-2025
Retractable Technologies Total Shareholders Equity 2011-2026 | RVP
Annual Total Shareholders Equity Retractable Technologies
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 87.2 M | 99.3 M | 107 M | 99.2 M | 49.9 M | 28.5 M | 25.6 M | 27.2 M | 28.1 M | 30.8 M | 26.6 M | 28.9 M | 35.7 M | 38.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 107 M | 25.6 M | 50.9 M |
Quarterly Total Shareholders Equity Retractable Technologies
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 76.8 M | 76.5 M | 76.6 M | 87.2 M | 83.5 M | 85.4 M | 99.7 M | 99.3 M | 99.4 M | 104 M | 107 M | 107 M | 109 M | 102 M | 105 M | 99.2 M | 79.6 M | 74.6 M | 67.8 M | 49.9 M | 49.9 M | 49.9 M | 49.9 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 25.6 M | 25.6 M | 25.6 M | 25.6 M | 27.2 M | 27.2 M | 27.2 M | 27.2 M | 28.1 M | 28.1 M | 28.1 M | 28.1 M | 30.8 M | 31 M | 31 M | 31 M | 26.6 M | 26.8 M | 26.8 M | 26.8 M | 28.7 M | 28.9 M | 28.9 M | 28.9 M | 35.7 M | 35.7 M | 35.7 M | 35.7 M | 38.7 M | 38.7 M | 38.7 M | 38.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 109 M | 25.6 M | 51.2 M |
Total Shareholders Equity of other stocks in the Medical instruments industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Atrion Corporation
ATRI
|
243 K | - | - | $ 810 M | ||
|
Baxter International
BAX
|
6.96 B | $ 19.94 | 1.06 % | $ 10.2 B | ||
|
ICU Medical
ICUI
|
1.97 B | $ 149.15 | -0.59 % | $ 3.64 B | ||
|
Repro Med Systems
KRMD
|
20.4 M | $ 5.36 | -1.65 % | $ 244 M | ||
|
OraSure Technologies
OSUR
|
410 M | $ 2.76 | -1.08 % | $ 205 M | ||
|
Ekso Bionics Holdings
EKSO
|
12.7 M | $ 8.74 | 4.14 % | $ 176 M | ||
|
Alcon
ALC
|
18.8 B | $ 80.81 | -0.39 % | $ 40.4 B | ||
|
AtriCure
ATRC
|
461 M | $ 36.51 | -1.19 % | $ 1.71 B | ||
|
Haemonetics Corporation
HAE
|
821 M | $ 66.12 | 0.23 % | $ 3.33 B | ||
|
electroCore
ECOR
|
7.44 M | $ 6.56 | -7.61 % | $ 36.2 K | ||
|
AngioDynamics
ANGO
|
183 M | $ 10.33 | 3.51 % | $ 422 M | ||
|
InfuSystem Holdings
INFU
|
48 M | $ 8.25 | 2.61 % | $ 170 M | ||
|
STERIS plc
STE
|
6.6 B | $ 261.51 | -0.05 % | $ 25.8 B | ||
|
The Cooper Companies
COO
|
8.24 B | $ 80.56 | 0.24 % | $ 16 B | ||
|
Masimo Corporation
MASI
|
1.05 B | $ 135.1 | -0.85 % | $ 7.2 B | ||
|
Harvard Bioscience
HBIO
|
73.1 M | $ 0.51 | -5.5 % | $ 21.6 M | ||
|
Glaukos Corporation
GKOS
|
462 M | $ 118.29 | -0.56 % | $ 5.73 B | ||
|
Merit Medical Systems
MMSI
|
1.38 B | $ 81.27 | 1.28 % | $ 4.73 B | ||
|
Isoray
ISR
|
291 M | - | 0.03 % | $ 108 M | ||
|
iRhythm Technologies
IRTC
|
90.9 M | $ 152.4 | 2.29 % | $ 4.75 B | ||
|
LeMaitre Vascular
LMAT
|
337 M | $ 84.52 | 0.79 % | $ 1.9 B | ||
|
Intuitive Surgical
ISRG
|
16.4 B | $ 503.25 | -0.85 % | $ 179 B | ||
|
NeuroMetrix
NURO
|
14.3 M | - | 5.05 % | $ 9.02 M | ||
|
Utah Medical Products
UTMD
|
128 M | $ 61.3 | -0.57 % | $ 222 M | ||
|
Microbot Medical
MBOT
|
4.5 M | $ 1.82 | -2.16 % | $ 18.6 M | ||
|
Nephros
NEPH
|
8.36 M | $ 4.31 | -1.82 % | $ 44.8 M | ||
|
Milestone Scientific
MLSS
|
5.83 M | $ 0.3 | -0.5 % | $ 23.9 M | ||
|
Envista Holdings Corporation
NVST
|
2.93 B | $ 23.05 | -1.45 % | $ 3.97 B | ||
|
Pro-Dex
PDEX
|
36.6 M | $ 39.41 | 0.01 % | $ 130 M | ||
|
Predictive Oncology
POAI
|
-203 K | - | - | $ 31.1 M | ||
|
Pulse Biosciences
PLSE
|
44.4 M | $ 13.67 | 0.37 % | $ 657 M | ||
|
Becton, Dickinson and Company
BDX
|
25.4 B | $ 202.08 | 0.49 % | $ 58.1 B | ||
|
Repligen Corporation
RGEN
|
1.96 B | $ 150.45 | -3.79 % | $ 8.38 M | ||
|
ResMed
RMD
|
3.36 B | $ 252.03 | -2.17 % | $ 36.8 B | ||
|
BioLife Solutions
BLFS
|
349 M | $ 22.01 | -2.52 % | $ 1.01 B | ||
|
Stereotaxis
STXS
|
16.3 M | $ 2.25 | -3.43 % | $ 182 M | ||
|
STAAR Surgical Company
STAA
|
397 M | $ 18.85 | -0.48 % | $ 926 M | ||
|
Teleflex Incorporated
TFX
|
4.28 B | $ 104.3 | -1.12 % | $ 4.89 B | ||
|
West Pharmaceutical Services
WST
|
2.68 B | $ 228.04 | -1.98 % | $ 16.6 B | ||
|
DENTSPLY SIRONA
XRAY
|
1.94 B | $ 12.36 | 0.73 % | $ 2.51 B |